Page last updated: 2024-10-24

cetylpyridinium and Cystic Fibrosis

cetylpyridinium has been researched along with Cystic Fibrosis in 1 studies

Cetylpyridinium: Cationic bactericidal surfactant used as a topical antiseptic for skin, wounds, mucous membranes, instruments, etc.; and also as a component in mouthwash and lozenges.

Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Selimovic, A1
Mujicic, E1
Milisic, S1
Mesihovic-Dinarevic, S1
Dzinovic, A1
Cengic, S1
Bakalovic, G1
Moro, M1
Djozic, M1
Lukic-Bilela, L1

Other Studies

1 other study available for cetylpyridinium and Cystic Fibrosis

ArticleYear
Analysis of Cystic Fibrosis in Federation of Bosnia and Herzegovina.
    Medical archives (Sarajevo, Bosnia and Herzegovina), 2015, Volume: 69, Issue:4

    Topics: Adolescent; Bosnia and Herzegovina; Cetylpyridinium; Child; Child, Preschool; Cystic Fibrosis; Femal

2015